AlphaFold’s Spinoff Just Raised $2.1 Billion to Prove AI Can Actually Design a Drug
Isomorphic Labs, the London-based drug-design company Alphabet spun out of Google DeepMind in 2021, closed a $2.1 billion Series B...
Isomorphic Labs, the London-based drug-design company Alphabet spun out of Google DeepMind in 2021, closed a $2.1 billion Series B...
On March 30, 2026, Eli Lilly and Hong Kong-based Insilico Medicine announced a research and licensing agreement worth up to...
A study published April 30, 2026 in the journal Science, led by researchers at Harvard Medical School and Beth Israel...
A team of researchers from the University of Oxford, University College London, and the UK AI Security Institute published a...
On May 12, 2026, Bayesian Health announced that its continuous sepsis-monitoring platform had received FDA 510(k) clearance — the first...
On April 2, 2026, the FDA sent a warning letter to Purolea Cosmetics Lab, a small homeopathic drug manufacturer in...
Leica Biosystems announced on August 11, 2026 that it had secured multiple FDA 510(k) clearances for its digital pathology portfolio,...
On May 6, 2026, Artera received FDA clearance for ArteraAI Breast, a tool the company describes as the first and...
Brain metastases are among the hardest things to count reliably on an MRI. A single scan can show one lesion...
On April 8, 2026, the FDA cleared an algorithm that claims to spot a disease most doctors never catch until...